Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lymphoma Channel: Aggressive T-Cell & NK-Cell Lymphoma

Explore the latest updates and expert interviews

The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Welcome to The Lymphoma Channel

VJHemOnc brings you key updates in aggressive NK- and T-cell lymphomas directly from leading researchers. The Aggressive T-cell & NK-cell Lymphoma Channel covers pivotal updates presented at major international congresses so that you can stay up-to-date through video interviews, podcasts and roundtable discussions with leading experts.

Peripheral T-Cell Lymphoma

View all
Updates in T-cell leukemia/lymphoma
Francine Foss et al. • 9 Oct 2024
Duvelisib for R/R PTCL: updates from the PRIMO trial 2:42
Duvelisib for R/R PTCL: updates from the PRIMO trial
Steven Horwitz • 6 Dec 2020

NK/T-Cell Lymphoma

View all
DR-01, an anti-CD94 monoclonal antibody, in the treatment of ultra-rare cytotoxic T-cell lymphomas 1:38
DR-01, an anti-CD94 monoclonal antibody, in the treatment of ultra-rare cytotoxic T-cell lymphomas
Swaminathan Iyer • 9 Dec 2024
Updates in T-cell leukemia/lymphoma
Francine Foss et al. • 9 Oct 2024

The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).

Diamond Supporter

AstraZeneca

Gold Supporter

Johnson & Johnson

Silver Supporter

Takeda

Bronze Supporter

Galapagos

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

If you are interested in becoming a supporter of The Lymphoma Channel, please contact us.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals